Franklin Genomic Advancements ETF Rating → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free HELX Stock Alerts $30.95 -0.29 (-0.93%) (As of 05/8/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy2.71Holdings in HELX have an aggregate rating of Moderate Buy based on 564 analyst ratings issued in the past year covering 46 companies (89.2% of the portfolio).HELX Aggregate Price Target$38.2623.61% UpsideHigh Prediction$48.82Average Prediction$38.26Low Prediction$28.18Holdings in HELX have an aggregate price target of $38.26 and a range of $28.18 to $48.82 covering 46 companies (89.2% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy31 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 HELX Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.73%MEDPMedpace$399.20+3.0%5 of 5 stars2.80$443.00 11.0%54.82%TMOThermo Fisher Scientific$577.93+0.7%5 of 5 stars2.71$607.35 5.1%174.73%REGNRegeneron Pharmaceuticals$968.00+1.3%4 of 5 stars2.70$981.71 1.4%204.68%VRTXVertex Pharmaceuticals$418.99+0.0%4 of 5 stars2.48$432.18 3.1%25Earnings ReportAnalyst Forecast4.29%LLYEli Lilly and Company$771.55-0.4%5 of 5 stars2.84$757.95 -1.8%19Earnings ReportDividend Announcement4.09%DHRDanaher$251.43+0.8%5 of 5 stars2.64$267.31 6.3%14Dividend Announcement3.90%KRYSKrystal Biotech$158.74+0.7%4 of 5 stars3.00$171.00 7.7%9Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.12%NTRANatera$95.55-0.1%2 of 5 stars3.00$86.40 -9.6%14High Trading Volume2.77%BRKRBruker$76.21+3.4%5 of 5 stars2.43$84.86 11.3%7Earnings ReportAnalyst Revision2.69%AZNAstraZeneca$77.61+0.8%2 of 5 stars2.57$81.00 4.4%72.40%CRLCharles River Laboratories International$230.09-2.2%5 of 5 stars2.64$253.23 10.1%11News Coverage2.32%MRNAModerna$122.69+0.7%4 of 5 stars2.25$126.89 3.4%16Earnings ReportAnalyst ForecastAnalyst Revision2.32%IONSIonis Pharmaceuticals$39.47-1.7%4 of 5 stars2.71$59.54 50.8%14Earnings ReportAnalyst ForecastInsider SellingNews CoveragePositive News2.24%CTVACorteva$57.83+1.8%4 of 5 stars2.73$63.24 9.4%22Analyst ForecastInsider Selling2.22%CDNSCadence Design Systems$285.28+1.0%5 of 5 stars2.78$326.11 14.3%92.20%AAgilent Technologies$145.14+1.6%4 of 5 stars2.59$141.29 -2.6%172.04%RCKTRocket Pharmaceuticals$23.33+1.5%5 of 5 stars2.89$52.13 123.4%9Earnings ReportAnalyst ForecastAnalyst Revision1.93%EXASExact Sciences$54.15-9.0%4 of 5 stars2.92$99.07 82.9%14News CoverageGap DownHigh Trading Volume1.91%QGENQiagen$43.58+1.5%4 of 5 stars2.56$50.95 16.9%9Analyst Revision1.79%BNTXBioNTech$92.06+2.1%3 of 5 stars2.27$118.82 29.1%11Analyst ForecastOptions VolumeNews Coverage1.75%SRPTSarepta Therapeutics$132.30-0.2%4 of 5 stars2.79$160.60 21.4%14Insider SellingAnalyst Revision1.58%ICLRICON Public$315.04+1.1%4 of 5 stars3.00$339.44 7.7%8Positive News1.44%FDMT4D Molecular Therapeutics$25.64-2.6%2 of 5 stars3.00$44.22 72.5%101.35%ALNYAlnylam Pharmaceuticals$151.37-0.6%5 of 5 stars2.59$216.19 42.8%17Earnings ReportAnalyst Forecast1.34%NTLAIntellia Therapeutics$24.86+8.1%4 of 5 stars2.69$67.00 169.5%13News CoverageGap Up1.32%RVTYRevvity$104.34+1.5%3 of 5 stars2.54$118.17 13.3%13Positive News1.28%VYGRVoyager Therapeutics$8.44-1.5%4 of 5 stars2.86$19.33 129.1%7Upcoming Earnings1.13%AZTAAzenta$52.51-2.9%2 of 5 stars2.33$68.40 30.3%6Earnings ReportAnalyst ForecastNews CoverageGap DownHigh Trading Volume1.13%IQVIQVIA$229.20+0.6%5 of 5 stars2.80$257.57 12.4%15Gap Down1.02%TECHBio-Techne$79.63+3.3%4 of 5 stars2.82$80.50 1.1%111.02%RGENRepligen$164.89-0.4%4 of 5 stars2.89$197.75 19.9%9Analyst Revision1.01%TWSTTwist Bioscience$43.20+4.3%2 of 5 stars3.00$42.50 -1.6%6Earnings ReportAnalyst ForecastInsider Selling0.94%RAREUltragenyx Pharmaceutical$41.22-0.8%4 of 5 stars2.92$87.85 113.1%12Earnings ReportAnalyst Forecast0.94%LHLaboratory Co. of America$206.15+2.3%5 of 5 stars2.79$243.14 17.9%140.81%NBIXNeurocrine Biosciences$139.66+0.5%5 of 5 stars2.74$147.88 5.9%23Analyst Revision0.80%CRSPCRISPR Therapeutics$53.55+0.5%3 of 5 stars2.38$77.23 44.2%17Earnings ReportUpcoming EarningsAnalyst ForecastNews Coverage0.76%INSMInsmed$26.38+1.5%4 of 5 stars3.00$44.92 70.3%12Analyst DowngradeNews CoverageGap Up0.69%CDMOAvid Bioservices$8.14-2.9%3 of 5 stars2.75$14.50 78.1%40.65%BMYBristol-Myers Squibb$44.74+2.5%5 of 5 stars2.11$60.00 34.1%190.63%LGNDLigand Pharmaceuticals$86.12+7.2%5 of 5 stars3.00$116.33 35.1%3Earnings ReportAnalyst ForecastNews CoverageHigh Trading Volume0.62%BBIOBridgeBio Pharma$28.73+3.7%4 of 5 stars2.80$47.82 66.4%100.62%BIOBio-Rad Laboratories$277.31+3.4%5 of 5 stars2.80$461.00 66.2%5Earnings ReportAnalyst Forecast0.60%BEAMBeam Therapeutics$22.54+1.3%2 of 5 stars2.38$40.18 78.3%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.55%UTHRUnited Therapeutics$266.05+1.9%5 of 5 stars2.90$308.78 16.1%10Insider Selling0.52%AVTRAvantor$24.77+2.0%5 of 5 stars2.75$26.71 7.8%16Positive News0.49%SDGRSchrödinger$23.14-0.3%3 of 5 stars2.67$42.80 85.0%9 This page (BATS:HELX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
